Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Colorectal Neoplasms

  Free Subscription


11.11.2019

1 Am J Clin Oncol
1 Ann Surg Oncol
4 BMC Cancer
1 BMC Gastroenterol
2 Cancer Lett
1 Cancer Res
2 Eur J Cancer
3 Gastroenterology
1 Int J Cancer
1 Int J Colorectal Dis
1 Oncogene
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Oncol

  1. TAI CC, Chen WS, Jiang JK, Yang SH, et al
    Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer.
    Am J Clin Oncol. 2019 Nov 5. doi: 10.1097/COC.0000000000000637.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  2. WATSON MM, Kanani A, Lea D, Khajavi RB, et al
    Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) in Colorectal Cancer is Associated with an Elderly, Frail Phenotype and Improved Recurrence-Free Survival.
    Ann Surg Oncol. 2019 Nov 4. pii: 10.1245/s10434-019-08048.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. KALMAR A, Nagy ZB, Galamb O, Csabai I, et al
    Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
    BMC Cancer. 2019;19:1059.
    PubMed     Text format     Abstract available

  4. AHIKO Y, Shida D, Horie T, Tanabe T, et al
    Controlling nutritional status (CONUT) score as a preoperative risk assessment index for older patients with colorectal cancer.
    BMC Cancer. 2019;19:946.
    PubMed     Text format     Abstract available

  5. STRICKLER JH, Rushing CN, Niedzwiecki D, McLeod A, et al
    A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer.
    BMC Cancer. 2019;19:1032.
    PubMed     Text format     Abstract available

  6. MARTIN SZ, Wagner DC, Horner N, Horst D, et al
    Ex vivo tissue slice culture system to measure drug-response rates of hepatic metastatic colorectal cancer.
    BMC Cancer. 2019;19:1030.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  7. LIU J, Tang L, Yi J, Li G, et al
    Unique characteristics of CpG island methylator phenotype (CIMP) in a Chinese population with colorectal cancer.
    BMC Gastroenterol. 2019;19:173.
    PubMed     Text format     Abstract available


    Cancer Lett

  8. DE VERA AA, Gupta P, Lei Z, Liao D, et al
    Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.
    Cancer Lett. 2019;442:91-103.
    PubMed     Text format     Abstract available

  9. EILERTSEN IA, Moosavi SH, Stromme JM, Nesbakken A, et al
    Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer.
    Cancer Lett. 2019 Oct 30. pii: S0304-3835(19)30543.
    PubMed     Text format     Abstract available


    Cancer Res

  10. ZHOU J, Liu Y, Zhang Y, Li Q, et al
    Modeling tumor evolutionary dynamics to predict clinical outcomes for patients with metastatic colorectal cancer: a retrospective analysis.
    Cancer Res. 2019 Nov 1. pii: 0008-5472.CAN-19-1940.
    PubMed     Text format     Abstract available


    Eur J Cancer

  11. SOLDEVILLA B, Carretero-Puche C, Gomez-Lopez G, Al-Shahrour F, et al
    The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
    Eur J Cancer. 2019;123:118-129.
    PubMed     Text format     Abstract available

  12. DUCREUX M, Petersen LN, Ohler L, Bergamo F, et al
    Safety and effectiveness of regorafenib in patients with metastatic colorectal cancer in routine clinical practice in the prospective, observational CORRELATE study.
    Eur J Cancer. 2019;123:146-154.
    PubMed     Text format     Abstract available


    Gastroenterology

  13. BURNETT-HARTMAN AN, Newcomb PA, Peters U
    Challenges with colorectal cancer family history assessment: motivation to translate polygenic risk scores into practice.
    Gastroenterology. 2019 Nov 1. pii: S0016-5085(19)41483.
    PubMed     Text format    

  14. CARETHERS JM, Doubeni CA
    Causes of Socioeconomic Disparities in Colorectal Cancer and Intervention Framework and Strategies.
    Gastroenterology. 2019 Nov 1. pii: S0016-5085(19)41482.
    PubMed     Text format     Abstract available

  15. LITWIN O, Sontrop JM, McArthur E, Tinmouth J, et al
    Uptake of Colorectal Cancer Screening by Physicians is Associated With Greater Uptake by Their Patients.
    Gastroenterology. 2019 Oct 31. pii: S0016-5085(19)41480.
    PubMed     Text format     Abstract available


    Int J Cancer

  16. GE W, Hu H, Cai W, Xu J, et al
    High-risk stage III colon cancer patients identified by a novel 5-gene mutational signature are characterized by up-regulation of IL-23A and gut bacterial translocation of the tumor microenvironment.
    Int J Cancer. 2019 Nov 6. doi: 10.1002/ijc.32775.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  17. DAVINI F, Ricciardi S, Zirafa CC, Romano G, et al
    Lung metastasectomy after colorectal cancer: prognostic impact of resection margin on long term survival, a retrospective cohort study.
    Int J Colorectal Dis. 2019 Nov 4. pii: 10.1007/s00384-019-03386.
    PubMed     Text format     Abstract available


    Oncogene

  18. ZHOU B, Zong S, Zhong W, Tian Y, et al
    Interaction between laminin-5gamma2 and integrin beta1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins.
    Oncogene. 2019 Nov 1. pii: 10.1038/s41388-019-1082.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  19. KODAMA T, Marian TA, Lee H, Kodama M, et al
    MRTFB suppresses colorectal cancer development through regulating SPDL1 and MCAM.
    Proc Natl Acad Sci U S A. 2019 Nov 5. pii: 1910413116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: